Phoenix Life Sciences International Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PLSI research report →
About the company
Phoenix Life Sciences International Limited operates as a global healthcare solutions provider, conducting business in the United States and internationally. The company primarily concentrates on pioneering research, developing integrated programs, and producing goods aimed at the prevention and treatment of a broad spectrum of conditions. These include diabetes, pain, and various cancers, as well as psychological, gastrointestinal, autoimmune, neurological, and sleep disorders.
- CEO
- Willis Victory
- IPO
- 2011
- Employees
- 5
- HQ
- Las Vegas, NV, US
Price Chart
- Market Cap
- $365.91K
- P/E
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -0.07
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -71.46%
- ROIC
- -30.24%
- Revenue
- $0 · 0.00%
- Net Income
- $-3,117,000 · -3969.72%
- EPS
- $-89.11 · -3522.36%
- Op Income
- $-3,062,000
- FCF YoY
- -187679.48%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 204.07
- Avg Volume
- 1.15K
Get TickerSpark's AI analysis on PLSI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our PLSI coverage
Recent articles, reports, and earnings notes.
No research on PLSI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PLSI report →Similar companies
Peers in the same neighborhood.